Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Plos One|October 3, 2013
A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic diseaseTohru Fujiwara, Takashi Ikeda, Yuki Nagasaka, et al.
Internal Medicine (Tokyo, Japan)|September 9, 2010
Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemiaSatoshi Ichikawa, Noriko Fukuhara, Joji Yamamoto, et al.
The Journal of Biological Chemistry|February 5, 2014
3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiationTohru Fujiwara, Haruka Saitoh, Ai Inoue, et al.
Internal Medicine (Tokyo, Japan)|April 5, 2021
Salvage Cord Blood Transplantation for Sustained Remission of Acute Megakaryoblastic Leukemia That Relapsed Early after Myeloablative TransplantationSatoshi Ichikawa, Tohru Fujiwara, Kei Saito, et al.
Experimental Hematology|February 15, 2026
Heme Synthesis Inhibition Induces the Intrinsic Apoptosis Pathway in Leukemia with OSGIN1 UpregulationYan Yan, Hiroki Kato, Sayaka Sano, et al.
International Journal of Hematology|December 27, 2023
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphomaShinichi Makita, Shuichi Ota, Yuko Mishima, et al.
Surgical Case Reports|July 8, 2018
Classical Hodgkin lymphoma-type and monomorphic-type post-transplant lymphoproliferative disorder following liver transplantation: a case reportHiroyuki Kumata, Chikashi Nakanishi, Keigo Murakami, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|February 16, 2021
Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case reportKoichi Onodera, Yasushi Onishi, Jun Inoue, et al.
International Journal of Clinical Oncology|June 15, 2026
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trialDai Maruyama, Hideki Goto, Takahiro Kumode, et al.
Plos One|October 3, 2012
Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cellsTohru Fujiwara, Hisayuki Yokoyama, Yoko Okitsu, et al.
Pageof 17